Nan Limvorasak, PharmD BCOP
Los Angeles
Summary
Experienced in managing oncology clinical trials in high-stress environments, I possess expertise in personnel leadership, resource management, and key decision-making. My problem-solving approach is articulate and analytical, enabling me to effectively address issues that impact team performance and station results. With a motivational mindset, I consistently drive success and exceed expectations.
Overview
20
20
years of professional experience
1
1
Certification
Work History
Pharmacy Program Coordinator, Investigational Drug
Cedars-Sinai Medical Center
11.2013 - Current
- Managed over 500 oncology clinical trials.
- Established and led implementation of electronic drug accountability system.
- Developed logistic plan for affiliated sites participating in a clinical trial.
- Created operational workflow necessary system interface for electronic health record, electronic drug accountability and research database.
- Developed effective communication strategies for improved collaboration among team members, resulting in increased productivity.
- Facilitated regular meetings with team members to discuss progress updates, address challenges, and brainstorm solutions for ongoing success.
- Led training sessions for staffs and clinical team , fostering a knowledgeable and cohesive team environment.
- Monitored performance metrics closely to evaluate areas requiring intervention or adjustment, making data-informed decisions that contributed positively towards overall results.
- Maintained detailed records of program activities and participant data, ensuring compliance with internal policies and external regulations.
- Managed budgets, ancillary agreement, site contract and resources for successful execution of multiple programs simultaneously.
- Assisted in the development of grant proposals, investigator initiated trials and securing funding for vital program initiatives.
- Created comprehensive reports on program progress, presenting findings to stakeholders and adjusting strategies as needed.
- Provided exceptional pharmacy services, addressing inquiries and resolving issues promptly.
- Led training sessions for staff and volunteers, fostering a knowledgeable and cohesive team environment.
- Enhanced program efficiency by streamlining processes and implementing innovative solutions.
- Improved team collaboration with establishment of regular coordination meetings and updates.
- Served as medical monitor for the data safety and monitoring committee (DSMC).
- Served as ancillary reviewer for the institutional review board (IRB) and scientific reviewer for the protocol reviewing and monitoring committee (PRMC).
- Provided quality assurance and ensured protocol compliance, resulting in multiple successful audits by the external and federal agencies.
Pharmacy Consultant Manager
Hartford Healthcare Cancer Institute
11.2019 - 11.2022
- Provided guidance and reviewed on various standard operating procedure to manage multiple locations within its care delivery system.
- Implemented innovative strategies to reduce medication costs without compromising patient care or satisfaction levels.
- Assisted with data analysis and benchmark for research pharmacy fee structure and performance metrics.
- Leveraged data analytics to identify opportunities for cost savings, formulary optimization, and improved utilization management processes.
- Optimized pharmacy operations by implementing efficient inventory management systems and streamlining workflow processes.
- Mentored junior pharmacists and other study team member to enhance their skills and performance in a supportive and growth-oriented environment.
- Developed comprehensive drug policies, ensuring safe and effective use of medications within healthcare organizations.
Clinical Oncology Pharmacist
Cedars-Sinai Medical Center
06.2011 - 11.2013
- Advanced the quality of pharmaceutical care for oncology patients through continuous professional development and research initiatives.
- Strengthened relationships between the pharmacy department and other healthcare disciplines through effective communication and teamwork initiatives.
- Led efforts to maintain compliance with regulatory standards relating to hazardous drug handling in an oncology setting.
- Ensured safe medication practices by conducting thorough medication reviews for oncology patients.
- Enhanced workflow efficiency through regular review of procedures and implementation of process improvements within the oncology pharmacy department.
- Improved patient outcomes by implementing evidence-based oncology treatment protocols.
- Provided specialized drug information to physicians, nurses, and other healthcare providers, enhancing oncology treatment decision making.
- Evaluated emerging trends in pharmacotherapy for cancer treatment, ensuring incorporation into standard practice when warranted.
- Collaborated with interdisciplinary teams for comprehensive cancer care and optimal patient management.
- Developed and conducted educational programs to enhance healthcare professionals'' knowledge of oncology treatments.
- Implemented an efficient system for managing chemotherapy orders, minimizing preparation time and errors.
- Participated in tumor board meetings, offering valuable input on pharmaceutical interventions in cancer treatment plans.
- Assisted in the development of clinical trials, ensuring safe and effective testing of new cancer therapies.
Clinical Pharmacist Specialist
University of Chicago Medical Center
04.2010 - 06.2011
- Played an integral role in oncology drug management, providing expert guidance on appropriate drug therapy interventions during critical moments of patient care.
- Educated patients on proper medication use and adherence, leading to improved health outcomes and decreased hospital readmissions.
- Trained pharmacy residents and interns on clinical care and medication dispensing.
- Educated other healthcare professionals on possible drug interactions, potential side effects, and optimal methods of administration.
- Streamlined pharmacy operations, leading team to adopt electronic prescription systems.
- Enhanced clinical pharmacy services through the development and implementation of evidence-based protocols and guidelines.
- Evaluated medication regimens for complex patients, identifying potential drug interactions and devising alternative treatment strategies when necessary.
- Participated in quality improvement initiatives to optimize clinical pharmacy services within the organization.
- Collaborated with healthcare providers to tailor medication plans for complex cases.
- Implemented cost-saving measures through formulary management and utilization review, ensuring efficient use of resources while maintaining high-quality patient care standards.
- Collaborated with interdisciplinary healthcare teams for optimal patient care and improved treatment outcomes.
Research Associate
University of Chicago Medical Center
06.2005 - 03.2010
- Validated incoming data to check information accuracy and integrity while independently locating and correcting concerns.
- Presented research findings at industry conferences, increasing visibility for the organization.
- Conducted comprehensive literature reviews to inform study designs and methodology decisions.
Clinical Pharmacist
University of Chicago Medical Center
06.2005 - 03.2010
- Reviewed physician orders for accuracy, dosage, frequency of chemotherapy schedule, potential drug-drug interaction, adverse reactions, and the inclusion of appropriate supportive care medications for all adults and pediatric oncology patients.
- Resolved operational problems related to interpretation of prescriptions, drug furnishing irregularities, service complaints and technical problems including drug procurement or equipment needs, according to established policies and procedures.
- Recognized for ability to manage a high volume of patient accounts
- Supervised pharmacy technicians and provide managerial responsibilities for the operation of the hematology/oncology decentralized pharmacy
- Led institutional oncology pharmacist training program
- Participated in multidisciplinary team and provided recommendation on dose adjustment, supportive care therapy and other drug information.
- Prepared and updated oncology drug formulary.
- Advanced the quality of pharmaceutical care for oncology patients through continuous professional development and research initiatives.
- Ensured safe medication practices by conducting thorough medication reviews for oncology patients.
- Enhanced workflow efficiency through regular review of procedures and implementation of process improvements within the oncology pharmacy department.
- Streamlined medication therapy management, reducing adverse drug reactions in cancer patients.
- Optimized patient satisfaction by providing personalized pharmaceutical care and addressing individual needs and concerns.
- Improved patient outcomes by implementing evidence-based oncology treatment protocols.
Staff Pharmacist
St. Mary and Elizabeth Medical Center
04.2005 - 06.2005
- Reviewed physician orders for accuracy and perform medication order entry in computer system
- Consulted and assisted with pharmacokinetics and antibiotic dosing
- Consulted and assisted with INR monitoring and adjust warfarin dosing
Education
Doctor of Pharmacy -
University of Florida
Gainesville, FL05-2008
Skills
- Persuasive communication style
- Training coordination
- Strategic planning
- Office administration and project management
Certification
- Board Certified Oncology Pharmacist (BCOP) - Board of Pharmacy Specialties (BPS) 2009 - present.
- Registered Pharmacist - California Board of Pharmacy
- Registered Pharmacist - Illinois
- Basic Life Support (BLS) - American Heart Association 2011 - present.
- Good Clinical Practice (GCP) - The Collaborative Institutional Training Initiative (CITI Program) 2011 - present.
Affiliations
- American Society of Clinical Oncology (ASCO)
- American Society of Health System Pharmacist (ASHP)
- Hematology Oncology Pharmacy Association (HOPA)
- NRG Oncology
- Children's Oncology Group (COG)
Institutional Committee Activities
- Data Safety and Monitoring Committee (DSMC), 2019 - present
- Beacon Research Operation, 2019 - present
- Beacon Research Working Group, 2016 - present
- Oncology Pharmacy & Therapeutic Committee, 2016 - present
- Institutional Review Board, 2013 - present
- Clinical Research Leadership Committee, 2019 - present
- Cedars-Sinai Cancer Disease Research Group (DRG) Leadership Committee, 2019 - present
- Cedars-Sinai Cancer Grand Rounds Planning Committee, 2022 - present
- Cedars-Sinai Cancer DEI Seminar Series Planning Committee, 2023 - present
- Protocol Review and Monitoring Committee (PRMC), 2011-2019
Key Presentations and Invited Speaker
- ASCO Annual Meeting 2023. System-wide approach on biosimilars adoption in oncology: strategic plan on switching and cost savings.
- SITC 2023. Advances in Cancer Immunotherapy Gastrointestinal Cancers, Society for Immunotherapy of Cancer
- NCCN Annual Meeting 2021. Optimizing a Systemic Platform to Standardize Oncologic Biosimilars Utilizations at Cedars-Sinai Medical Center.
- HOPA Annual Conference 2018. Improving quality of cancer care through patient experience: Patient reported outcome (PRO) in clinical trials vs. clinical practice. Breakout Session: Practice Leadership.
- HOPA Annual Conference 2017. Value of cancer care, which model is best?
- HOPA Recertification Course 2020. Immune Checkpoint Inhibitor Therapy in Patients with HIV infection.
- HOPA Webinar Series 2019. Emerging Issues in Oncology – ASCO Hematology Focus Webinar.
Publications
- Limvorasak S, Kyung K, Dobbs CL, et al. System-wide approach on biosimilars adoption in oncology: strategic plan on switching and cost savings. J Clin Oncol. 2023; 41(16):1600.
- Finnes HD, Child B, Defrates S, Kinsman K, Thorne A, Lentz S, Lockhorst R, Murphy J, Urmanski A, Amin S, Barr H, Baviskar S, Beckman C, Chow N, Derba M, Erickson M, Hennes E, Heisey H, Lau R, Limvorasak S, Luckritz T, Mays T, Nzelibe CN, Romanowski T, Smith C, Tesoro D, Toeniskoetter K, Voytilla K. Adapting investigational drug services during a pandemic: Recommendations for future preparedness from the Hematology/Oncology Pharmacy Association Investigational Drug Services Special Interest Group. Am J Health Syst Pharm. 2023 Jan 1;80(1):e-67-e73.
- Limvorasak S, Dobbs CL, Kyung K, et al. Successful Biosimilar Adoption in Oncology: Strategic Approach to System Standardization. J Clin Oncol. 2022; 40(16):18605.
- Limvorasak S, Teaford H, Dobbs CL, et al. Optimizing a Systemic Platform to Standardize Oncologic Biosimilars Utilizations at Cedars-Sinai Medical Center. J Natl Compr Canc Netw. 2022 Mar;20(3). doi: 10.6004/jnccn.2021.7289.
- Posadas EM, Chen JF, Scher K, Tripathi M, Lu YT, Montes A, Go A, Ureno A, Cavassani K, Sievert M, Rogatko A, Limvorasak S, Oppenheim A, Moldawer N, Chung L, Bhowmick N, Tseng HR, Figlin RA. Circulating tumor cell subsets and macrophage polarization predict effectiveness of Cabozantinib in advanced prostate cancer with visceral metastases. J Clin Oncol. 2017; 35(15): 5031.
- Posadas EM, Limvorasak S, Figlin RA. Targeted therapies for renal cell carcinoma. Nature Reviews Nephrology. 2017 Aug;13(8):496-511.
- Posadas EM, Limvorasak S, Sharma S, Figlin RA. Targeting angiogenesis in renal cell carcinoma. Expert Opin Pharmacother. 2013 Oct 10.
- Mosmi S, Robinson M, Nandi S, Faoro L, Demchuk C, Rolle CE, Kanteti R, Ferguson BJ, Hasina R, Gadgadhar TC, Salama AK, Kirchner C, Mendonca E, Campbell N, Limvorasak S, Villaflor V, Krauz T, Vokes EE, Husain AN, Karrison T, Salgia R. Proteomic Characterization of Non-Small Cell Lung Cancer in a Comprehensive Translational Thoracic Oncology Database. Journal of Translational Medicine. J Clin Bioinforma. 2011 Feb 28;1(8):1-11.
Research
- Identification of risk factors associated with severe immune-related adverse events from immune checkpoint inhibitors (IRIS), 2024 – present. Role: Principal Investigator.
- Implementation of a pharmacist-based, post chemotherapy follow-up clinic, 2023 - present. Role: Principal Investigator.
- Optimize systemic platform to assure quality, value and evidence-based decision making on biosimilar products use in oncology, 2021-2023. Role: Principal Investigator. NCCN/Pfizer Biosimilars/Grant# 64087263.
- Improving safety and quality of cancer care in patients receiving checkpoint inhibitors for treatment of advanced malignancies (I-CARE), 2017-2020. Role: Principal Investigator.
- Electronic Medical Record (EMR) for CTSU Pilot of clinical trial electronic medication order template, a service of the National Cancer Institute (NCI) designed to facilitate access to NCI-funded clinical trials. 2016-2018. Role: Collaborator.
- Optimizing cancer care by integrating value-based oncology into computerized physician order entry (CPOE): A pilot study in the Thoracic Oncology Disease Related Group. 2017-2018. Role: Sub-Investigator.
Timeline
Pharmacy Consultant Manager
Hartford Healthcare Cancer Institute
11.2019 - 11.2022
Pharmacy Program Coordinator, Investigational Drug
Cedars-Sinai Medical Center
11.2013 - Current
Clinical Oncology Pharmacist
Cedars-Sinai Medical Center
06.2011 - 11.2013
Clinical Pharmacist Specialist
University of Chicago Medical Center
04.2010 - 06.2011
Research Associate
University of Chicago Medical Center
06.2005 - 03.2010
Clinical Pharmacist
University of Chicago Medical Center
06.2005 - 03.2010
Staff Pharmacist
St. Mary and Elizabeth Medical Center
04.2005 - 06.2005
- Board Certified Oncology Pharmacist (BCOP) - Board of Pharmacy Specialties (BPS) 2009 - present.
- Registered Pharmacist - California Board of Pharmacy
- Registered Pharmacist - Illinois
- Basic Life Support (BLS) - American Heart Association 2011 - present.
- Good Clinical Practice (GCP) - The Collaborative Institutional Training Initiative (CITI Program) 2011 - present.
Doctor of Pharmacy -
University of Florida
Similar Profiles
Imelda DiazImelda Diaz
Cardiovascular Technician at Cedars-Sinai Medical CenterCardiovascular Technician at Cedars-Sinai Medical Center
Crystina PargaCrystina Parga
Licensed Vocational Nurse, Float Pool at Cedars Sinai Medical CenterLicensed Vocational Nurse, Float Pool at Cedars Sinai Medical Center
Chamnan NannChamnan Nann
Program/Project Coordinator at Cedars-Sinai Medical CenterProgram/Project Coordinator at Cedars-Sinai Medical Center